Immunoprecise Antibodies has announced that it has opened a new subsidiary office in Cambridge, Massachusetts, US.
The company is a Canadian contract research organisation (CRO) providing a range of services, including antibody discovery, manufacturing, optimisation, engineering and pre-clinical studies.
CEO of IPA Jennifer Bath said: “With production sites in Canada and the Netherlands, and the executive headquarters in the North Dakota, establishing a base in the Boston / Cambridge area, a powerhouse for biotech and pharma, is a strategic next step for IPA. We already have a strong base of both European and US clients, and this move will help us enhance and grow our Boston area business and relationships”.
The new office is located at One Broadway, 14th floor, Cambridge, MA 02142 and will initially be staffed for sales and business development initiatives.
Bath added: “There is a tremendous demand for pioneering antibody discovery and development services in the greater Boston area, the largest US biotech hub, and we are excited to provide day-to-day access to our clients and prospective clients as we continue to offer an unparalleled continuum of antibody discovery and downstream technologies”.